Angelo Ranieri

Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study

Piero Barbanti, Gabriella Egeo, Cinzia Aurilia et al. · The Journal of Headache and Pain · 2023 · 58 citations · Full text

Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing - Remitting Multiple Sclerosis

Giorgia Teresa Maniscalco, Mario Annunziata, Angelo Ranieri et al. · Multiple Sclerosis and Related Disorders · 2020 · 46 citations

Autoimmune Disease, Immunology, Hematology +5

Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study

Raffaele Ornello, Carlo Baraldi, Simona Guérzoni et al. · The Journal of Headache and Pain · 2022 · 45 citations · Full text

Narrative Medicine to integrate patients’, caregivers’ and clinicians’ migraine experiences: the DRONE multicentre project

Maria Clara Tonini, Alessandra Fiorencis, Rosario Iannacchero et al. · Neurological Sciences · 2021 · 31 citations · Full text

Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men

Raffaele Ornello, Carlo Baraldi, Simona Guérzoni et al. · Frontiers in Neurology · 2021 · 28 citations · Full text